Alzheimer's disease: progress in prediction.
作者信息
Petersen Ronald C
机构信息
Alzheimer's Disease Research Center, Mayo Clinic College of Medicine, Rochester, MN, USA.
出版信息
Lancet Neurol. 2010 Jan;9(1):4-5. doi: 10.1016/S1474-4422(09)70330-8.
Abstract
摘要
相似文献
1
Alzheimer's disease: progress in prediction.阿尔茨海默病：预测方面的进展
Lancet Neurol. 2010 Jan;9(1):4-5. doi: 10.1016/S1474-4422(09)70330-8.
2
The effect of APOE genotype on clinical phenotype in Alzheimer disease.载脂蛋白E基因（APOE）基因型对阿尔茨海默病临床表型的影响。
Neurology. 2007 Feb 20;68(8):624; author reply 624. doi: 10.1212/01.wnl.0000258354.96336.97.
3
The effects of stress and APOE genotype on cognition in older adults.压力和载脂蛋白E基因分型对老年人认知的影响。
Am J Psychiatry. 2008 Nov;165(11):1376-8. doi: 10.1176/appi.ajp.2008.08081249.
4
Research criteria for the diagnosis of Alzheimer's disease: genetic risk factors, blood biomarkers and olfactory dysfunction.阿尔茨海默病诊断的研究标准：遗传风险因素、血液生物标志物与嗅觉功能障碍。
Int Psychogeriatr. 2008 Aug;20(4):853-5. doi: 10.1017/S1041610208006807. Epub 2008 Apr 17.
5
Nature throws curveballs: APOE and nonlinear decline in Alzheimer disease.大自然变幻莫测：载脂蛋白E与阿尔茨海默病的非线性衰退
Neurology. 2005 Dec 27;65(12):1855-6. doi: 10.1212/01.wnl.0000195338.67756.4b.
6
fMRI evidence of compensatory mechanisms in older adults at genetic risk for Alzheimer disease.针对有患阿尔茨海默病遗传风险的老年人，功能磁共振成像（fMRI）显示其存在代偿机制的证据。
Neurology. 2005 Nov 8;65(9):1514-5; author reply 1514-5. doi: 10.1212/wnl.65.9.1514-a.
7
Alzheimer's Disease Neuroimaging Initiative biomarkers as quantitative phenotypes: Genetics core aims, progress, and plans.阿尔茨海默病神经影像学倡议生物标志物作为定量表型：遗传学核心目标、进展和计划。
Alzheimers Dement. 2010 May;6(3):265-73. doi: 10.1016/j.jalz.2010.03.013.
8
[Signaling molecules in the brain and epigenetic factors in neurodegenerative and mental disorders].[大脑中的信号分子以及神经退行性疾病和精神障碍中的表观遗传因素]
Zh Nevrol Psikhiatr Im S S Korsakova. 2015;115(10):102-110. doi: 10.17116/jnevro2015115101102-110.
9
Relationship between cortisol levels and memory performance may be modulated by the presence or absence of cognitive impairment: evidence from healthy elderly, mild cognitive impairment and Alzheimer's disease subjects.皮质醇水平与记忆表现之间的关系可能受到认知障碍存在与否的调节：来自健康老年人、轻度认知障碍和阿尔茨海默病患者的证据。
J Alzheimers Dis. 2010;19(3):839-48. doi: 10.3233/JAD-2010-1282.
10
APOE epsilon 4 allele predicts faster cognitive decline in mild Alzheimer disease.APOE ε4等位基因预示着轻度阿尔茨海默病患者认知功能衰退更快。
Neurology. 2008 May 6;70(19 Pt 2):1842-9. doi: 10.1212/01.wnl.0000304038.37421.cc. Epub 2008 Apr 9.
引用本文的文献
1
A glycan biomarker predicts cognitive decline in amyloid- and tau-negative patients.一种聚糖生物标志物可预测淀粉样蛋白和tau蛋白阴性患者的认知衰退。
Brain Commun. 2024 Oct 18;6(6):fcae371. doi: 10.1093/braincomms/fcae371. eCollection 2024.
2
FGFR3 drives Aβ-induced tau uptake.成纤维细胞生长因子受体 3 驱动 Aβ 诱导的 tau 摄取。
Exp Mol Med. 2024 Jul;56(7):1631-1642. doi: 10.1038/s12276-024-01274-3. Epub 2024 Jul 1.
3
Evaluation of serum neurofilament light chain and glial fibrillary acidic protein in the diagnosis of Alzheimer's disease.血清神经丝轻链和胶质纤维酸性蛋白在阿尔茨海默病诊断中的评估
Front Neurol. 2024 Jan 30;15:1320653. doi: 10.3389/fneur.2024.1320653. eCollection 2024.
4
Validation of the Antioxidant and Enzyme Inhibitory Potential of Selected Triterpenes Using In Vitro and In Silico Studies, and the Evaluation of Their ADMET Properties.使用体外和计算研究验证选定三萜类化合物的抗氧化和酶抑制潜力，并评估它们的 ADMET 性质。
Molecules. 2021 Oct 20;26(21):6331. doi: 10.3390/molecules26216331.
5
Identifying Individuals With Mild Cognitive Impairment Using Working Memory-Induced Intra-Subject Variability of Resting-State EEGs.利用工作记忆诱发的静息态脑电图个体内变异性识别轻度认知障碍个体
Front Comput Neurosci. 2021 Aug 4;15:700467. doi: 10.3389/fncom.2021.700467. eCollection 2021.
6
Association between handgrip strength and cognition in a Chinese population with Alzheimer's disease and mild cognitive impairment.中国人握手力量与认知的关联：患有阿尔茨海默病和轻度认知障碍人群的研究。
BMC Geriatr. 2021 Aug 11;21(1):459. doi: 10.1186/s12877-021-02383-8.
7
Phytochemical Composition, Antioxidant Activity, and Enzyme Inhibitory Activities (α-Glucosidase, Xanthine Oxidase, and Acetylcholinesterase) of .[植物名称]的化学成分、抗氧化活性以及对α-葡萄糖苷酶、黄嘌呤氧化酶和乙酰胆碱酯酶的抑制活性。
Molecules. 2021 Jul 24;26(15):4472. doi: 10.3390/molecules26154472.
8
Prognostic value of amyloid/tau/neurodegeneration (ATN) classification based on diagnostic cerebrospinal fluid samples for Alzheimer's disease.基于诊断性脑脊液样本的淀粉样蛋白/tau/神经退行性变（ATN）分类对阿尔茨海默病的预后价值。
Alzheimers Res Ther. 2021 Apr 20;13(1):84. doi: 10.1186/s13195-021-00817-4.
9
Automated Multiclass Classification of Spontaneous EEG Activity in Alzheimer's Disease and Mild Cognitive Impairment.阿尔茨海默病和轻度认知障碍中自发脑电活动的自动多类分类
Entropy (Basel). 2018 Jan 9;20(1):35. doi: 10.3390/e20010035.
10
Differential Expression and miRNA-Gene Interactions in Early and Late Mild Cognitive Impairment.早期和晚期轻度认知障碍中的差异表达及miRNA-基因相互作用
Biology (Basel). 2020 Aug 28;9(9):251. doi: 10.3390/biology9090251.
本文引用的文献
1
Alzheimer's Disease Neuroimaging Initiative (ADNI): clinical characterization.阿尔茨海默病神经影像学倡议（ADNI）：临床特征。
Neurology. 2010 Jan 19;74(3):201-9. doi: 10.1212/WNL.0b013e3181cb3e25. Epub 2009 Dec 30.
2
Mild cognitive impairment: ten years later.轻度认知障碍：十年之后
Arch Neurol. 2009 Dec;66(12):1447-55. doi: 10.1001/archneurol.2009.266.
3
Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer's disease.全基因组关联研究确定了CLU和CR1基因中与阿尔茨海默病相关的变异。
Nat Genet. 2009 Oct;41(10):1094-9. doi: 10.1038/ng.439. Epub 2009 Sep 6.
4
Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease.全基因组关联研究确定了与阿尔茨海默病相关的CLU和PICALM基因变体。
Nat Genet. 2009 Oct;41(10):1088-93. doi: 10.1038/ng.440. Epub 2009 Sep 6.
5
CSF biomarkers and incipient Alzheimer disease in patients with mild cognitive impairment.轻度认知障碍患者的脑脊液生物标志物与早期阿尔茨海默病
JAMA. 2009 Jul 22;302(4):385-93. doi: 10.1001/jama.2009.1064.
6
Prevalence and prognostic value of CSF markers of Alzheimer's disease pathology in patients with subjective cognitive impairment or mild cognitive impairment in the DESCRIPA study: a prospective cohort study.DESCRIPA研究中主观认知障碍或轻度认知障碍患者脑脊液阿尔茨海默病病理标志物的患病率及预后价值：一项前瞻性队列研究
Lancet Neurol. 2009 Jul;8(7):619-27. doi: 10.1016/S1474-4422(09)70139-5. Epub 2009 Jun 10.
7
Serial PIB and MRI in normal, mild cognitive impairment and Alzheimer's disease: implications for sequence of pathological events in Alzheimer's disease.正常、轻度认知障碍和阿尔茨海默病患者的连续淀粉样蛋白成像和磁共振成像：对阿尔茨海默病病理事件顺序的启示
Brain. 2009 May;132(Pt 5):1355-65. doi: 10.1093/brain/awp062. Epub 2009 Mar 31.
8
Cerebrospinal fluid biomarker signature in Alzheimer's disease neuroimaging initiative subjects.阿尔茨海默病神经影像学计划受试者的脑脊液生物标志物特征
Ann Neurol. 2009 Apr;65(4):403-13. doi: 10.1002/ana.21610.
9
Episodic memory loss is related to hippocampal-mediated beta-amyloid deposition in elderly subjects.发作性记忆丧失与老年受试者海马介导的β-淀粉样蛋白沉积有关。
Brain. 2009 May;132(Pt 5):1310-23. doi: 10.1093/brain/awn320. Epub 2008 Nov 28.
Zotero 插件